Attentin 20 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

attentin 20 mg tabletter

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tabletter - 20 mg

Medikinet 10 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medikinet 10 mg tabletter

medice arzneimittel pütter gmbh & co. kg - methylphenidathydrochlorid - tabletter - 10 mg

Medikinet 20 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medikinet 20 mg tabletter

medice arzneimittel pütter gmbh & co. kg - methylphenidathydrochlorid - tabletter - 20 mg

Rinvoq Den Europæiske Union - dansk - EMA (European Medicines Agency)

rinvoq

abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Audalis 10 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

audalis 10 mg filmovertrukne tabletter

medice arzneimittel pütter gmbh & co. kg - atomoxetinhydrochlorid - filmovertrukne tabletter - 10 mg

Attentin 10 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

attentin 10 mg tabletter

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tabletter - 10 mg

Attentin 5 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

attentin 5 mg tabletter

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tabletter - 5 mg

Medikinet 5 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medikinet 5 mg tabletter

medice arzneimittel pütter gmbh & co. kg - methylphenidathydrochlorid - tabletter - 5 mg